The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.
Summer Meeting 2019Join us in Manchester 14th to 17th July 2019
Visualising Psychotropic Medicine (VPM)Presenting what can be a complex set of data in a useful and engaging way
Online CPD ResourceRCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Fundamentals of Clinical PsychopharmacologyBuy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
The Ten Secrets of Success in ScienceView Professor Trevor Robbins presenting his top tips
Neuroscience-based Nomenclature (NbN) for JoPJournal of Psychopharmacology chosen to trial new NbN
Fundamentals Wins BMA AwardFundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Benefits of BAP membership include:
- FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
- Reduced registration fees for the annual Summer Meeting.
- Half price subscription to the Online CPD Resource.
- Eligibility for prizes and awards.
- Student bursaries for the BAP Summer Meeting and international conferences.
- Reduced registration fees for selected partner association events.
- 50% OFF Royal Society of Biology membership (Read more)
- BAP Newsletter.
- Voting for BAP Officers and Council (full members only).
- Being part of one of the largest national psychopharmacology associations in the world.
|1st November 2018||Street Drugs in the Big Smoke: Perspective and Policy||Henry Thomas Room, London Metropolitan University, Holloway Road, London|
|8th November 2018||Society for the Study of Addiction Conference||Crowne Plaza hotel, Newcastle upon Tyne|
|21st November 2018||Day A: Schizophrenia / Substance Misuse||Hallam Conference Centre 44 Hallam Street London|
SYMPOSIUM 5: New concepts in the co-morbidity of psychiatric disorders, eating disorders and obesity.
By Sarah Stuart
Posted on 3rd August 2018
Underlying metabolic disturbances are often ignored when treating psychiatric disorders and can even be exacerbated with treatments, but it is becoming more apparent that these metabolic issues may not arise a result of treatment, but may instead be pre-existing in psychosis. This session echoed the theme of schizophrenia and its co-morbidity with eating disorders that […]
SYMPOSIUM 3: Microglia role in neuropsychiatric disease and its potential as a treatment target
By Ciaran Fitzpatrick
Posted on 30th July 2018
(chaired by Valeria Mondelli & Peter Talbot) Given that clinical, genetic and pharmacological findings indicate that inflammatory molecules and their associated pathways are enhanced in neuropsychiatric disorders such as major depressive disorder and schizophrenia, Monday morning’s symposium 3 dealt with the importance of microglia cells in these disorders. Microglia are immune...
Post-Doc Symposium 1: What can animal behaviours really tell us about human cognitive and emotional processes?
By Sarah Stuart
Posted on 30th July 2018
The amount of preclinical data being presented at the BAP Summer Meeting has been dwindling over the years, in favour of clinical and non-clinical human research. This post-doctoral symposium was put together by myself and Dr Claire Hales from the University of Bristol to showcase preclinical work and to highlight the importance of using translational […]
Hip Hop Psych supported by The State at the City Art Centre in Edinburgh as part of Thrive Edinburgh
7th September 2018
CoDI Show: Why is mental illness so goddam controversial?
Stephen talks about his CoDI show, which explores why he thinks mental illness is needlessly controversial
11th August 2018
Postnatal depression in fathers
Andrew spoke to LBC Radio about postnatal depression in men, also covered by The Guardian
10th August 2018
When words fail, music speaks: How music can help children with autism connect
Drs. Samata Sharma and Frank Tarazi from Harvard Medical School wrote an article for the World Economic Forum on the use of music as adjunctive therapy for children with autism
14th June 2018
The Guardian: This revolution in our understanding of depression will be life-transforming
Ed wrote an article for The Guardian about the genetics of depression.
29th April 2018
|Mental health in young people - Press Briefing |
24th July 2018
Press coverage of the successful press briefing on 20th July on the importance of early intervention in mental illness in young people.
|2018 Statistical Excellence in the Pharmaceutical Industry Award |
18th July 2018
Simon Bate and Robin Clark win 2018 Statistical Excellence in the Pharmaceutical Industry Award for their development of InVivoStat
|New Curriculum for Research Animals |
13th June 2018
A new curriculum for University education in the use of research animals has just been launched.
|Alzheimer’s researchers win world’s top brain research prize |
6th March 2018
Four neuroscientists working in the UK, Belgium and Germany have today (6 March) won the world’s most valuable prize for brain research
Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.